Measuring the quality of care in metastatic colorectal cancer: a scoping review of quality indicators
JNCI Cancer Spectrum · 2024
DOI: 10.1093/jncics/pkae073 ↗Kurz gefasst
Scoping Review in der Zeitschrift JNCI Cancer Spectrum, 2024. Verfasst von Catherine Dunn und 3 weiteren Autor:innen. Beteiligte Einrichtung: Personalised Oncology Division, Walter and Eliza Hall Institute, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Palliative Care, Quality Indicators, Health Care, Terminal Care. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Quality indicators are essential for measuring and benchmarking the quality of cancer care. Although there are well-established metrics for early-stage colorectal cancer (CRC), few exist for advanced CRC. This scoping review aimed to collate and review all quality indicators for metastatic CRC.
Methods
A dedicated search was performed of Web of Science, PubMed, CINAHL, and relevant gray literature to identify quality indicators for metastatic CRC, evaluating the diagnostic workup, systemic anticancer treatments, surgical approaches, radiation approaches, supportive care, and palliative or terminal care provided to patients.
Results
We identified 11 articles, of which 5 were systematized reviews and 6 concerned the development, validation, or operationalization of quality indicators. Thirty-five distinct quality indicators for metastatic CRC were extracted across 6 domains of care: 1) diagnosis, staging, and treatment planning; 2) systemic anticancer treatment; 3) radiation oncology; 4) surgical approaches; 5) supportive care; and 6) palliative and end-of-life care, with a general quality indicator of overall survival. Of the 35 quality indicators extracted, 8 (23%) were unique to metastatic CRC and 27 (77%) were generic quality indicators across different tumor types but applicable to metastatic CRC.
Conclusion
There are few quality indicators specifically relevant to metastatic CRC. Those that do exist are generally generic process measures used across tumor types and do not measure the nuance or complexity of current multidisciplinary treatment of patients with metastatic CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Personalised Oncology Division, Walter and Eliza Hall Institute, Melbourne, Victoria, Australia.
- Health Sciences, The University of Melbourne, Melbourne, Victoria, Australia.
- Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.
- Radiation Oncology Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
ORCID-Profile: Catherine Dunn, Michael T Halpern, Daniel Sapkaroski, Peter Gibbs
Zitieren
APA
Dunn, C., Halpern, M. T., Sapkaroski, D., & Gibbs, P. (2024). Measuring the quality of care in metastatic colorectal cancer: a scoping review of quality indicators. JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkae073
Vancouver
Dunn C, Halpern MT, Sapkaroski D, Gibbs P. Measuring the quality of care in metastatic colorectal cancer: a scoping review of quality indicators. JNCI Cancer Spectrum. 2024. doi:10.1093/jncics/pkae073
BibTeX
@article{Dunn2024,
author = {Dunn, Catherine and Halpern, Michael T and Sapkaroski, Daniel and Gibbs, Peter},
title = {Measuring the quality of care in metastatic colorectal cancer: a scoping review of quality indicators},
journal = {JNCI Cancer Spectrum},
year = {2024},
doi = {10.1093/jncics/pkae073}
}
EUVIMED